Application 210542
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS USA INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE | CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE | TABLET;ORAL | 50MG;500MG | No | No |
| 002 | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE | CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE | TABLET;ORAL | 50MG;1000MG | No | No |
| 003 | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE | CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE | TABLET;ORAL | 150MG;500MG | No | No |
| 004 | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE | CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE | TABLET;ORAL | 150MG;1000MG | No | No |
Source provenance: Browse the complete Orange Book source catalog.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 73768 | ORIG | 2023-03-15 |